149 related articles for article (PubMed ID: 9614552)
1. Induction of apoptosis in the rheumatoid synovium by Fas ligand gene transfer.
Okamoto K; Asahara H; Kobayashi T; Matsuno H; Hasunuma T; Kobata T; Sumida T; Nishioka K
Gene Ther; 1998 Mar; 5(3):331-8. PubMed ID: 9614552
[TBL] [Abstract][Full Text] [Related]
2. Novel gene therapy for rheumatoid arthritis by FADD gene transfer: induction of apoptosis of rheumatoid synoviocytes but not chondrocytes.
Kobayashi T; Okamoto K; Kobata T; Hasunuma T; Kato T; Hamada H; Nishioka K
Gene Ther; 2000 Mar; 7(6):527-33. PubMed ID: 10757027
[TBL] [Abstract][Full Text] [Related]
3. Antirheumatic effects of humanized anti-Fas monoclonal antibody in human rheumatoid arthritis/SCID mouse chimera.
Matsuno H; Yudoh K; Nakazawa F; Sawai T; Uzuki M; Nishioka K; Yonehara S; Nakayama J; Ohtsuki M; Kimura T
J Rheumatol; 2002 Aug; 29(8):1609-14. PubMed ID: 12180717
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic effect of the anti-Fas antibody on arthritis in HTLV-1 tax transgenic mice.
Fujisawa K; Asahara H; Okamoto K; Aono H; Hasunuma T; Kobata T; Iwakura Y; Yonehara S; Sumida T; Nishioka K
J Clin Invest; 1996 Jul; 98(2):271-8. PubMed ID: 8755634
[TBL] [Abstract][Full Text] [Related]
5. Amelioration of lymphoid hyperplasia and hypergammaglobulinemia in lupus-prone mice (gld) by Fas-ligand gene transfer.
Hong NM; Masuko-Hongo K; Sasakawa H; Kato T; Shirai T; Okumura K; Nishioka K; Kobata T
J Autoimmun; 1998 Aug; 11(4):301-7. PubMed ID: 9776707
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of Fas-mediated apoptosis of rheumatoid synoviocytes by tumor necrosis factor alpha and basic fibroblast growth factor is associated with the expression of apoptosis-related molecules.
Kobayashi T; Okamoto K; Kobata T; Hasunuma T; Kato T; Hamada H; Nishioka K
Arthritis Rheum; 2000 May; 43(5):1106-14. PubMed ID: 10817565
[TBL] [Abstract][Full Text] [Related]
7. Potential withdrawal of rheumatoid synovium by the induction of apoptosis using a novel in vivo model of rheumatoid arthritis.
Sakai K; Matsuno H; Morita I; Nezuka T; Tsuji H; Shirai T; Yonehara S; Hasunuma T; Nishioka K
Arthritis Rheum; 1998 Jul; 41(7):1251-7. PubMed ID: 9663483
[TBL] [Abstract][Full Text] [Related]
8. Elimination of rheumatoid synovium in situ using a Fas ligand 'gene scalpel'.
Zhang H; Gao G; Clayburne G; Schumacher HR
Arthritis Res Ther; 2005; 7(6):R1235-43. PubMed ID: 16277676
[TBL] [Abstract][Full Text] [Related]
9. Adenoviral mediated delivery of FAS ligand to arthritic joints causes extensive apoptosis in the synovial lining.
Yao Q; Glorioso JC; Evans CH; Robbins PD; Kovesdi I; Oligino TJ; Ghivizzani SC
J Gene Med; 2000; 2(3):210-9. PubMed ID: 10894267
[TBL] [Abstract][Full Text] [Related]
10. Suppression of osteoclastogenesis in rheumatoid arthritis by induction of apoptosis in activated CD4+ T cells.
Ogawa Y; Ohtsuki M; Uzuki M; Sawai T; Onozawa Y; Nakayama J; Yonemura A; Kimura T; Matsuno H
Arthritis Rheum; 2003 Dec; 48(12):3350-8. PubMed ID: 14673986
[TBL] [Abstract][Full Text] [Related]
11. Novel mechanisms of selective apoptosis in synovial T cells of patients with rheumatoid arthritis.
Hoa TT; Hasunuma T; Aono H; Masuko K; Kobata T; Yamamoto K; Sumida T; Nishioka K
J Rheumatol; 1996 Aug; 23(8):1332-7. PubMed ID: 8856610
[TBL] [Abstract][Full Text] [Related]
12. Amelioration of collagen-induced arthritis by CD95 (Apo-1/Fas)-ligand gene transfer.
Zhang H; Yang Y; Horton JL; Samoilova EB; Judge TA; Turka LA; Wilson JM; Chen Y
J Clin Invest; 1997 Oct; 100(8):1951-7. PubMed ID: 9329958
[TBL] [Abstract][Full Text] [Related]
13. In situ expression of protooncogenes and Fas/Fas ligand in rheumatoid arthritis synovium.
Asahara H; Hasunuma T; Kobata T; Inoue H; Muller-Ladner U; Gay S; Sumida T; Nishioka K
J Rheumatol; 1997 Mar; 24(3):430-5. PubMed ID: 9058644
[TBL] [Abstract][Full Text] [Related]
14. Decoy receptor 3 expressed in rheumatoid synovial fibroblasts protects the cells against Fas-induced apoptosis.
Hayashi S; Miura Y; Nishiyama T; Mitani M; Tateishi K; Sakai Y; Hashiramoto A; Kurosaka M; Shiozawa S; Doita M
Arthritis Rheum; 2007 Apr; 56(4):1067-75. PubMed ID: 17393415
[TBL] [Abstract][Full Text] [Related]
15. T cell receptor of Fas-sensitive T cells in rheumatoid synovium.
Sumida T; Hoa TT; Asahara H; Hasunuma T; Nishioka K
J Immunol; 1997 Feb; 158(4):1965-70. PubMed ID: 9029139
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor alpha regulation of the FAS-mediated apoptosis-signaling pathway in synovial cells.
Kobayashi T; Okamoto K; Kobata T; Hasunuma T; Sumida T; Nishioka K
Arthritis Rheum; 1999 Mar; 42(3):519-26. PubMed ID: 10088775
[TBL] [Abstract][Full Text] [Related]
17. Expression of sentrin, a novel antiapoptotic molecule, at sites of synovial invasion in rheumatoid arthritis.
Franz JK; Pap T; Hummel KM; Nawrath M; Aicher WK; Shigeyama Y; Müller-Ladner U; Gay RE; Gay S
Arthritis Rheum; 2000 Mar; 43(3):599-607. PubMed ID: 10728754
[TBL] [Abstract][Full Text] [Related]
18. Gene therapy that inhibits nuclear translocation of nuclear factor kappaB results in tumor necrosis factor alpha-induced apoptosis of human synovial fibroblasts.
Zhang HG; Huang N; Liu D; Bilbao L; Zhang X; Yang P; Zhou T; Curiel DT; Mountz JD
Arthritis Rheum; 2000 May; 43(5):1094-105. PubMed ID: 10817564
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis in rheumatoid arthritis--expression of Fas, Fas-L, p53, and Bcl-2 in rheumatoid synovial tissues.
Chou CT; Yang JS; Lee MR
J Pathol; 2001 Jan; 193(1):110-6. PubMed ID: 11169523
[TBL] [Abstract][Full Text] [Related]
20. A novel bystander effect involving tumor cell-derived Fas and FasL interactions following Ad.HSV-tk and Ad.mIL-12 gene therapies in experimental prostate cancer.
Hall SJ; Canfield SE; Yan Y; Hassen W; Selleck WA; Chen SH
Gene Ther; 2002 Apr; 9(8):511-7. PubMed ID: 11948376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
